Rome, 25 November. (askanews) - A new appointment of “Principi Attivi”, a series of events promoted by Boehringer Ingelheim Italia, held in Rome at Palazzo Santa Chiara entitled “Italian health between tradition, recovery and resilience”. At the heart of the debate are the most urgent public health priorities, starting from the legislative foundations up to the impact on patients, families and society. Here are the words of Morena Sangiovanni, President and CEO of Boehringer Ingelheim:
“This is the fourth appointment of Principi Attivi, Boehringer Ingelheim’s format to focus the spotlight on issues related to health care that we consider to be particular priorities for us and for citizens and we do so through the most important players in our system be involved in. a particularly current topic, “Italian health between tradition, recovery and resilience”, also taking into account that we are halfway towards a deadline 2026 regarding the objectives of the PNRR and the budget law that is currently being discussed in the Chamber of Deputies regarding the budget law we cannot hide a strong concern about the underfunding of the National Health Fund and pharmaceuticals, a driving force for growth.
Local assistance and partnership between public and private are the main elements of the words of the Undersecretary of the Ministry of Business and Made in Italy, Massimo Bitonci.
“However, a central theme in the PNRR is the theme of healthcare. There are important resources because I remember that there are almost 14 billion resources, and many of them are also dedicated to local healthcare. There are sectors where the public can to do a lot, for example on the whole topic of telemedicine on the topic of artificial intelligence, so on the topic of digitization, there are almost 4 billion of public and private funding available”.
Spotlight on the right to health in relation to the structural problems that must be overcome two years after the PNRR expired, an opportunity for change that must be fully seized.
How does the integration of traditional healthcare practices with modern approaches impact patient trust and engagement in Italy?
Interview between Time.news Editor and Morena Sangiovanni, President and CEO of Boehringer Ingelheim Italia
Time.news Editor: Good afternoon, Morena! It’s great to have you with us today. The recent event titled “Italian health between tradition, recovery, and resilience” sounds like a vital discussion for our times. Can you elaborate on the key themes you explored during this event?
Morena Sangiovanni: Good afternoon! It’s a pleasure to be here. At the event, we delved into several pressing public health priorities, emphasizing the need to blend traditional practices with modern approaches to healthcare. We discussed legislative frameworks, their implications on patient care, and how recovery and resilience can shape the future of Italian health.
Time.news Editor: You mentioned the blending of tradition and recovery. How do you see this interplay impacting public health policies in Italy?
Morena Sangiovanni: It’s crucial. Integrating traditional practices with contemporary models can foster a more holistic approach to healthcare. For instance, understanding local health customs can enhance patient experience and compliance. Policymakers must recognize these cultural elements when drafting health regulations to create effective and sustainable public health strategies.
Time.news Editor: You also touched on the impact of these policies on patients, families, and society as a whole. What are some tangible effects you’ve noticed in your work?
Morena Sangiovanni: Absolutely! When health policies are attuned to the needs of families and communities, we see better health outcomes. For instance, when patients feel that their cultural values are respected within the healthcare system, it promotes trust and encourages them to seek care promptly. This trust can lead to a more proactive approach to health and wellness, which, in turn, alleviates pressure on our healthcare resources.
Time.news Editor: Speaking about resources, how has the recovery from recent public health challenges, such as the COVID-19 pandemic, influenced your approach at Boehringer Ingelheim?
Morena Sangiovanni: The pandemic underscored the need for resilience in health systems. At Boehringer Ingelheim, we are focusing on innovation and collaboration to address the gaps highlighted during the pandemic. This includes investing in research for treatment options and fostering partnerships with local healthcare providers to ensure that we are agile and responsive to emerging health needs.
Time.news Editor: That sounds like a proactive approach! Can you share some specific initiatives that Boehringer Ingelheim is undertaking in this context?
Morena Sangiovanni: Certainly! One initiative is our ongoing support for educational programs aimed at healthcare professionals. We believe in empowering those on the front lines with the knowledge and tools they need to address complex health issues. Additionally, we are investing in digital health solutions to improve patient engagement and streamline processes in clinical settings.
Time.news Editor: With all these initiatives, do you see a path forward for strengthening the Italian healthcare system?
Morena Sangiovanni: Yes, I genuinely believe that by nurturing collaboration between different sectors—public health, private enterprises, and academic institutions—we can build a more resilient healthcare system. Our focus should always be on the patient at the center of care, ensuring that their needs and preferences guide our policies and practices.
Time.news Editor: Thank you, Morena, for sharing such insights. It’s clear that the road ahead for Italian healthcare, while challenging, is filled with opportunities for growth and improvement.
Morena Sangiovanni: Thank you for having me! It’s an exciting time in our field, and I’m optimistic about what we can achieve together.